4//SEC Filing
Sjuts Dustin S 4
Accession 0001479290-23-000116
CIK 0001479290other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:32 PM ET
Size
5.0 KB
Accession
0001479290-23-000116
Insider Transaction Report
Form 4
Sjuts Dustin S
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2023-12-15$8.08/sh−4,712$38,073→ 157,354 total
Footnotes (1)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on December 15, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock award (the "RSA") for 11,973 shares. The RSA vests in three equal annual installments from December 15, 2021.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001796224
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:32 PM ET
- Size
- 5.0 KB